Literature DB >> 4036719

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. A comparison of retinopathy in younger and older onset diabetic persons.

R Klein, M D Davis, S E Moss, B E Klein, D L DeMets.   

Abstract

In a population-based survey of diabetic persons, retinopathy was detected by stereoscopic color fundus photography in 70% of persons under 30 years of age at diagnosis and taking insulin (Group YO), in 62% of persons 30 years of age or older at diagnosis and taking insulin (Group OO-I) and in 36% of persons 30 years of age or older at diagnosis not taking insulin (Group OO-N). The mean duration of known diabetes was 14.6 years in Group YO, 11.0 years in Group OO-I and 6.9 years in Group OO-N. After 20 years of diabetes, proliferative retinopathy was present in about 50% of Group YO, about 25% of Group OO-I and about 5% of Group OO-N. After 15 years of diabetes, macular edema was present in about 18% of Group YO, about 20% of Group OO-I and about 12% of Group OO-N. When present, macular edema tended to be associated with more hard exudate in Group OO-N.

Entities:  

Mesh:

Year:  1985        PMID: 4036719     DOI: 10.1007/978-1-4757-1850-8_18

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Bimodal imaging of proliferative diabetic retinopathy vascular features using swept source optical coherence tomography angiography.

Authors:  Amal M Elbendary; Hossam Youssef Abouelkheir
Journal:  Int J Ophthalmol       Date:  2018-09-18       Impact factor: 1.779

2.  Heritability of the severity of diabetic retinopathy: the FIND-Eye study.

Authors:  Nedal H Arar; Barry I Freedman; Sharon G Adler; Sudha K Iyengar; Emily Y Chew; Mathew D Davis; Scott G Satko; Donald W Bowden; Ravi Duggirala; Robert C Elston; Xiuxing Guo; Robert L Hanson; Robert P Igo; Eli Ipp; Paul L Kimmel; William C Knowler; Julio Molineros; Robert G Nelson; Madeleine V Pahl; Shannon R E Quade; Rebekah S Rasooly; Jerome I Rotter; Mohammed F Saad; Marina Scavini; Jeffrey R Schelling; John R Sedor; Vallabh O Shah; Philip G Zager; Hanna E Abboud
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09       Impact factor: 4.799

3.  High HbA1c level was the most important factor associated with prevalence of diabetic retinopathy in Taiwanese type II diabetic patients with a fixed duration.

Authors:  Shwu-Jiuan Sheu; Ni-Chun Liu; Lu-Ping Ger; Wan-Ling Ho; Jiun-Yo Lin; Shih-Chou Chen; Yu-Harn Horng; Hing-Chung Lam
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-17       Impact factor: 3.117

Review 4.  Validation of structural and functional lesions of diabetic retinopathy in mice.

Authors:  T S Kern; J Tang; B A Berkowitz
Journal:  Mol Vis       Date:  2010-10-19       Impact factor: 2.367

5.  Retinal Neurodegeneration in db/db Mice at the Early Period of Diabetes.

Authors:  Qin Yang; Yidan Xu; Ping Xie; Haixia Cheng; Qinglu Song; Tu Su; Songtao Yuan; Qinghuai Liu
Journal:  J Ophthalmol       Date:  2015-03-02       Impact factor: 1.909

Review 6.  Epidemiological issues in diabetic retinopathy.

Authors:  Peter H Scanlon; Stephen J Aldington; Irene M Stratton
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec

7.  Prevalence of Diabetic Retinopathy in Type 1 and Type 2 Diabetes Mellitus Patients in North-East Poland.

Authors:  Wojciech Matuszewski; Angelika Baranowska-Jurkun; Magdalena M Stefanowicz-Rutkowska; Robert Modzelewski; Janusz Pieczyński; Elżbieta Bandurska-Stankiewicz
Journal:  Medicina (Kaunas)       Date:  2020-04-06       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.